So, assuming 2% growth, Gilead is slightly undervalued. In fact, Gilead appears valued for 0% growth. Actually, this may be a ...

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

There is a pervasive sense of fear — of losing access to critical health care services and of livelihoods lost,” CFK Africa ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Invite the Ukrainian president to the heartland of America. Show him and the world that we categorically denounce the treatment he received.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...